methotrexate has been researched along with Infection in 156 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 47 (30.13) | 18.7374 |
1990's | 16 (10.26) | 18.2507 |
2000's | 43 (27.56) | 29.6817 |
2010's | 42 (26.92) | 24.3611 |
2020's | 8 (5.13) | 2.80 |
Authors | Studies |
---|---|
Duvic, M; Joshi, TP | 1 |
Ha, YJ; Kang, EH; Lee, EB; Lee, JH; Lee, YJ; Shin, A | 1 |
Schmutz, JL | 1 |
Bijlsma, JWJ; de Hair, MJH; Devenport, J; Edwardes, MD; Jacobs, JWG; Luder, Y; Pethoe-Schramm, A; Safy-Khan, M; Teitsma, XM; van Laar, JM; Welsing, PMJ | 1 |
Bharucha, KN; Brunner, HI; Burgos-Vargas, R; Cuttica, R; de Benedetti, F; Douglass, W; Duarte, C; Espada, G; Job-Deslandre, C; Joos, R; Keltsev, V; Kimura, Y; Lovell, DJ; Martini, A; Penades, IC; Ruperto, N; Silverman, ED; Wells, C; Wimalasundera, S; Xavier, RM; Zavaler, MF; Zuber, Z | 1 |
Brunner, HI; Cimaz, R; Dare, J; Espada, G; Faugier, E; Ferrandiz, M; Gandhi, Y; Gerloni, V; Louw, I; Lovell, DJ; Martini, A; Nys, M; Passarell, J; Quartier, P; Ruperto, N; Silva, CA; Tzaribachev, N; Vega-Cornejo, G; Wagner-Weiner, L; Wong, R | 1 |
Brunello, L; Bruno, B; Busca, A; Butera, S; Cerrano, M; Dellacasa, CM; Faraci, DG; Giaccone, L; Mordini, N; Sorasio, R; Vassallo, S; Zallio, F | 1 |
Clauw, DJ; Kenney, B; Malani, PN; Nallamothu, BK; Waljee, AK; Wallace, BI | 1 |
Ch'ng, SS; Chong, HC; Gun, SC; Joshua Thundyil, R; Kan, SL; Lee, YYL; Lim, AL; Lim, CH; Loh, YL; Mohamed Ismail, A; Mohd Jamid, N; Mohd Noor, N; Ong, SG; Tan, BE; Teh, CL; Tsang, EEL | 1 |
Einarsson, JT; Evert, M; Geborek, P; Kapetanovic, MC; Lundgren, M; Saxne, T | 1 |
Abrahamowicz, M; Bernatsky, S; Curtis, JR; Guerra, SF; Machado, MAÁ; Moura, CS | 1 |
Ashcroft, DM; Evans, I; Griffiths, CEM; Lunt, M; McElhone, K; Murphy, R; Ormerod, AD; Reynolds, NJ; Smith, CH; Walton, S; Warren, RB; Yiu, ZZN | 1 |
Kneitz, C; Krüger, K | 1 |
Bessette, L; Durez, P; Fleischmann, R; Genovese, MC; Li, Y; Mysler, E; Ostor, AJ; Othman, AA; Pangan, AL; Peterfy, C; Song, IH; Zhou, Y | 1 |
Iwasaki, M; Izutsu, H; Kaneko, Y; Katayama, K; Kawakami, A; Rokuda, M; Shiomi, T; Takeuchi, T; Tanaka, S; Tanaka, Y; Ushijima, S; van der Heijde, D; Yamada, E | 1 |
Desai, RJ; Jin, Y; Kang, EH; Kim, SC; Tong, AY | 1 |
Singh, JA | 1 |
Dörner, T; Emery, P; Fisheleva, E; Martin, C; Millar, L; Olech, E; Rigby, W; Tak, PP; Travers, H | 1 |
Cantatore, FP; Corrado, A; D'Onofrio, F; Maruotti, N; Neve, A; Santoro, N | 1 |
Benda, B; Cohen, S; Gomez-Reino, JJ; Krishnaswami, S; Kwok, K; Nduaka, CI; Radominski, SC; Riese, R; Soma, K; Valdez, H; Wang, L; Wood, SP | 1 |
Brion, A; Chabin, M; Clavert, A; Colombat, P; Cumin, I; Delwail, V; Escoffre-Barbe, M; Gardembas, M; Ingrand, P; Lacotte-Thierry, L; Legouffe, E; Olivier, G; Solal-Celigny, P | 1 |
Buch, MH; Bukowski, J; Combe, B; Emery, P; FitzGerald, O; Gaylord, S; Hammoudeh, M; Krogulec, M; Martin-Mola, E; Pedersen, R; Vlahos, B; Williams, T | 1 |
Hashimoto, A; Matsui, T | 1 |
Dreyer, J; Gruenewald, T; Herscovici, C; Israeli, M; Levy-Assaraf, M; Mechoulam, R; Peck, A; Raanani, P; Ram, R; Shargian, L; Shpilberg, O; Yeshurun, M | 1 |
Deinlein, F; Fleischhack, G; Friedrich, C; Kuehl, J; Kwiecien, R; Lindow, C; Mynarek, M; Pompe, RS; Rutkowski, S; Treulieb, W; von Bueren, AO; von Hoff, K | 1 |
Arendt, C; Carter, D; Haraoui, B; Kavanaugh, A; Landewé, R; Mountian, I; Schiff, M; Smolen, JS; Strand, V; van der Heijde, D; van Vollenhoven, R; Vencovsky, J | 1 |
Ashcroft, DM; Burden, AD; Exton, LS; Griffiths, CEM; Jabbar-Lopez, Z; Mohd Mustapa, MF; Murphy, R; Owen, CM; Parslew, R; Samarasekera, EJ; Smith, CH; Venning, V; Warren, RB; Yiu, ZZN | 1 |
Ambrosetti, A; Balzarotti, M; Binder, M; Cavalli, F; Cwynarski, K; Deckert, M; Fabbri, A; Ferrari, A; Ferreri, AJ; Finke, J; Fox, CP; Gørløv, JS; Hemmaway, C; Hertenstein, B; Hess, G; Illerhaus, G; Johnson, P; Keller, U; Krause, SW; Levis, A; Linton, KM; Panse, J; Pisani, F; Politi, LS; Ponzoni, M; Pukrop, T; Pulczynski, E; Reni, M; Rosée, PL; Roth, A; Rudà, R; Schmoll, HJ; Schorb, E; Stilgenbauer, S; Torri, V; Tucci, A; Zucca, E | 1 |
Arendt, C; Bingham, CO; Burmester, GR; Bykerk, VP; Emery, P; Furst, DE; Mariette, X; Mountian, I; Purcaru, O; Tatla, D; van der Heijde, D; van Vollenhoven, R; VanLunen, B; Weinblatt, ME | 1 |
Carrascosa, JM; de Lucas, R; Galán, M; Pérez-Ferriols, A; Ribera, M; Yanguas, I | 1 |
Bauer, D; Burmester, GR; Graham, NM; Ignacio Vargas, J; Lee, EB; Lin, Y; Mangan, EK; Patel, R; van Adelsberg, J; van Hoogstraten, H | 1 |
Alten, R; Enríquez-Sosa, F; Greenwald, M; Harrison, P; Mazur, M; Pavlova, D; Tasset, C; Taylor, PC; Van der Aa, A; Vanhoutte, F; Westhovens, R | 1 |
Cseuz, R; Greenwald, M; Harrison, P; Kavanaugh, A; Kremer, J; Ponce, L; Reshetko, OV; Stanislavchuk, M; Tasset, C; Van der Aa, A; Vanhoutte, F | 1 |
Brophy, MT; Chang, BH; Hannagan, K; O'Dell, JR; Quach, LT; Soe Thwin, S | 1 |
Furuta, S; Iwamoto, I; Kagami, SI; Kashiwakuma, D; Kawashima, H; Takahashi, K; Yokota, M | 1 |
Boice, J; Colombel, JF; Cornillie, F; D'Haens, G; Ghosh, S; Hommes, DW; Huang, Z; Huyck, S; Lindgren, S; Panes, J; Prantera, C; Reinisch, W | 1 |
Gottlieb, AB; Korman, N; Krueger, GG; Sterry, W; Van De Kerkhof, P | 1 |
Ahmed, MA; Al-Tonbary, YA; El-Chennawi, FA; Mossad, YM | 1 |
Bobbio-Pallavicini, F; Caporali, R; Caprioli, M; Montecucco, C | 1 |
Salliot, C; van der Heijde, D | 1 |
Bishai, W; Greenberg, JD; Hochberg, MC; Kavanaugh, A; Kremer, JM; Reed, G; Tindall, E; Zheng, C | 1 |
Camacho, FM; Coronel-Pérez, IM; Pérez-Bernal, AM; Rodríguez-Rey, EM | 1 |
Bartoli, F; Decorti, G; Marino, S; Rabusin, M; Stocco, G; Tamaro, P; Verzegnassi, F | 1 |
Chott, A; Drach, J; Fridrik, MA; Geissler, D; Greil, R; Hausmaninger, H; Krieger, O; Lang, A; Michlmayr, G; Oberaigner, W; Ulsperger, E | 1 |
Andritsos, L; Bechtel, T; Benson, DM; Blum, W; Byrd, JC; Devine, SM; Elder, P; Garzon, R; Hamadani, M; Hofmeister, C; Klisovic, R; Krugh, D; Lin, T; Marcucci, G; O'Donnell, L; Penza, S; Phillips, G | 1 |
Bogas, M; Canhão, H; Costa, L; Fonseca, JE; Machado, P; Mourão, AF; Santos, MJ; Silva, JA | 1 |
Jones, G | 1 |
Savage, RL | 1 |
Balwierz, W; Cwiklińska, M; Stanuch, H | 1 |
Blanco Alonso, R; Rueda Gotor, J | 1 |
Becerra-Fernandez, E; Leandro, MJ | 1 |
Ambrosetti, A; Angrilli, F; Barbolini, E; Capodanno, I; Caracciolo, F; Carella, AM; Di Renzo, N; Federico, M; Galimberti, S; Ilariucci, F; Luminari, S; Merli, F; Petrini, M; Stelitano, C; Visco, C | 1 |
Ashrafzadeh, A; Bieraugel, R; Dudler, J; Dummer, W; Fleischmann, RM; Francom, S; Gomez-Reino, J; Green, J; Grzeschik, S; Olech, E; Stohl, W; Zerbini, CA | 1 |
Atzeni, F; Sarzi-Puttini, P | 1 |
Suzuki, Y | 1 |
Baildam, E; Brunner, HI; Burgos-Vargas, R; Calvo, I; Cuttica, R; De Benedetti, F; Dolezalova, P; Garay, SM; Grom, A; Joos, R; Kenwright, A; Lovell, D; Martini, A; Merino, R; Ravelli, A; Ruperto, N; Schneider, R; Woo, P; Wouters, C; Wright, S; Wulffraat, N; Xavier, R; Zemel, L; Zuber, Z; Zulian, F | 1 |
Abrams, K; Berkun, Y; Brik, R; Brunner, HI; Calvo, I; Cimaz, R; Constantin, T; Erguven, M; Ferrandiz, MA; Flato, B; Gamir, ML; Goffin, L; Grom, A; Hofer, M; Horneff, G; Kallinich, T; Kasapcopur, O; Kim, D; Kone-Paut, I; Lheritier, K; Lovell, DJ; Magnusson, B; Martini, A; McCann, L; Nistala, K; Oliveira, SK; Ozen, S; Quartier, P; Ruperto, N; Rutkowska-Sak, L; Schneider, R; Sztajnbok, F; Uziel, Y; Viola, S; Wouters, C; Wulffraat, N | 1 |
Caballero, D; Chopra, R; Craddock, C; García-Conde, J; Goldstone, AH; Hunter, A; Kottaridis, PD; Leon, A; Linch, DC; Mackinnon, S; Martino, R; Milligan, DW; Parker, A; Pérez-Simón, JA; San Miguel, JF; Schey, S; Sierra, J; Sureda, A; Urbano-Ispizua, A; Yong, K | 1 |
Amadori, S; Avvisati, G; Baccarani, M; Cantore, N; Di Bona, E; Ferrara, F; Fioritoni, G; Gallo, E; Invernizzi, R; Lazzarino, M; Liso, V; Lo-Coco, F; Mandelli, F; Mariani, G; Petti, MC; Ricciuti, F; Selleri, C; Sica, S; Vegna, ML; Veneri, D | 1 |
Amano, K; Takeuchi, T | 1 |
Asano, M; Bailey, LL; Cannarella, SN; Fagoaga, O; Gundry, SR; Izutani, H | 1 |
Daly, AS; Hasegawa, W; Jamal, H; Kiss, TL; Kotchetkova, N; Lipton, JH; Messner, HA; Yi, QL | 1 |
Centurioni, R; Corvatta, L; Leoni, F; Leoni, P; Malerba, L; Marconi, M; Masia, MC; Mele, A; Offidani, M; Scortechini, A | 1 |
FREI, E; FREIREICH, EJ | 1 |
Lange, U; Strube, K; Strunk, J | 1 |
Cabanillas, ME; Escalante, CP; Kantarjian, HM; Konopleva, M; O'Brien, SM; Pierce, SA; Thomas, DA; Weiser, MA | 1 |
Fleischmann, R; Iqbal, I; Stern, R | 1 |
Lovell, DJ; Sullivan, K; Zaoutis, TE | 1 |
Bamias, A; Bozas, G; Dimopoulos, MA; Efstathiou, E; Gika, D; Hamilos, G; Kakoyiannis, C; Kastritis, E; Moulopoulos, LA; Papadimitriou, C; Zorzou, MP | 1 |
Dadlani, C; Orlow, SJ | 1 |
Alamanos, Y; Bougias, DV; Drosos, AA; Nikas, SN; Temekonidis, TI; Voulgari, PV | 1 |
Keystone, EC; Kremer, JM; Martin, RW; Moreland, LW; Schiff, MH; Weinblatt, ME; White, BW; Whitmore, JB | 1 |
Berman, A; Geusens, P; Han, J; Rahman, MU; Strusberg, I; Westhovens, R; Yocum, D | 1 |
Aung, L; Kirk, RC; Liang, S; Quah, TC; Tan, RM; Yeoh, AE | 1 |
Abud-Mendoza, C; Becker, JC; Emery, P; Ge, Z; Genant, HK; Kremer, JM; Li, T; Moreland, LW; Russell, AS; Szechinski, J; Westhovens, R | 1 |
Hanada, R; Kigasawa, H; Kinoshita, A; Tabuchi, K; Tomizawa, D; Tsuchida, M; Tsukimoto, I | 1 |
Baker, D; Hegedus, R; Keenan, G; Smolen, J; St Clair, EW; Visvanathan, S; Wagner, C | 1 |
Arce, JA; Bollard, CM; Brenner, MK; Carrum, G; Gottschalk, S; Heslop, HE; Kennedy-Nasser, AA; Khan, SP; Krance, RA; Leung, KS; Mahajan, A; Weiss, HL | 1 |
Kuek, A; Ostör, AJ | 1 |
Blanche, S; de Saint Basile, G; Fischer, A; Mahlaoui, N; Neven, B; Ouachée-Chardin, M; Picard, C | 1 |
Abella, E; Bastida, P; Bethencourt, C; Bueno, J; del Potro, E; Feliu, E; Fernández-Abellán, P; Grande, C; Heras, I; Oriol, A; Ortega, JJ; Parody, R; Ribera, JM; Sanz, MA; Tormo, M | 1 |
Freireich, EJ | 1 |
Ojeda, VJ; Walters, MN | 1 |
Jacobs, C | 1 |
Liter, ME | 1 |
Brandt, SA; Edwards, JR; Goodman, S; Greer, JP; Leelasiri, A; Stein, RS; Wolff, SN | 1 |
Bijlsma, JW; Kruize, AA; van der Heide, A; van der Veen, MJ | 1 |
Ashley, S; Holborn, J; Jones, AL; Smith, IE | 1 |
Cassidy, JT; Giannini, EH | 1 |
Anasetti, C; Anderson, JE; Appelbaum, FR; Bensinger, WI; Bryant, E; Buckner, CD; Chauncey, T; Clift, RA; Gooley, T; Schoch, G | 1 |
Brodsky, I; Bulova, S; Crilley, P; Marks, DI; Styler, MJ; Topolsky, D | 1 |
Blay, JY; Bonnotte, B; Bourhis, JH; Burdiles, AM; Caignard, A; Carayol, G; Chehimi, J; Chouaib, S; Dietrich, PY; Hayat, M; Ibrahim, A; Kubin, M; Pardoux, C; Pico, JL; Robinet, E | 1 |
Baume, D; Bladou, F; Camerlo, J; Coulange, C; Cowen, D; Gravis, G; Lechevallier, E; Maraninchi, D; Resbeut, M; Serment, G; Viens, P | 1 |
Badellino, F; Canavese, G; Catturich, A; Gipponi, M; Repetto, L; Sertoli, MR; Tomei, D; Vecchio, C | 1 |
Connaghan, DG; Devine, SM; Dix, SP; Fitzsimmons, WE; Geller, RB; Heffner, LT; Hillyer, CD; Holland, HK; Keller, J; Lin, LB; Maher, RM; Maurer, D; O'Toole, K; Rodey, GE; Wingard, JR; Winton, EF | 1 |
Benesch, M; Kerbl, R; Lackner, H; Oberbauer, R; Pakisch, B; Schwinger, W; Urban, C | 1 |
Anasetti, C; Leisenring, W; Sanders, J; Sandmaier, BM; Storb, R; Stucki, A | 1 |
Carreras, E; Marín, P; Martínez, C; Montfort, N; Montserrat, E; Rovira, M; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
Eden, OB; Gibson, B; Hann, I; Hill, F; Kinsey, S; Lilleyman, J; Mitchell, C; Richards, S; Vora, A | 1 |
Dunn, R; Ferrara, J; Hutchinson, RJ; Levine, JE; Ratanatharathorn, V; Yanik, G | 1 |
Elonen, E; Juvonen, E; Parkkali, T; Ruutu, T; Volin, L | 1 |
Blume, KG; Hoppe, RT; Horning, SJ; Hu, WW; Johnston, LJ; Negrin, RS; Stockerl-Goldstein, KE | 1 |
Ancín, I; Berlanga, J; Ferrá, C; Gallardo, D; Gonzalez, JR; Grañena, A; Peris, J; Virgili, N | 1 |
Antin, JH; Bierer, BE; Cowan, MJ; Ho, WG; Jiao, J; Kaizer, H; Lazarus, HM; Linker, C; Miller, KB; Petersen, FB; Petrarca, MA; Schiller, GJ; Small, T; Territo, MC; Tonetta, SA; Wingard, JR; Winston, DJ; Wolff, SN | 1 |
Barcos, M; Bloomfield, CD; Freter, CE; Frizzera, G; Johnson, JL; Lee, EJ; Peterson, BA; Petroni, GR; Schiffer, CA | 1 |
Kabisch, H; Kröger, N; Krüger, W; Renges, H; Schetelig, J; Schrum, J; Siegert, W; Stute, N; Zabelina, T; Zander, AR | 1 |
Baruchel, A; Bertozzi, AI; Boutard, P; Frappaz, D; Laplanche, A; Mechinaud, F; Michon, J; Nelken, B; Patte, C; Schmitt, C | 1 |
Coblyn, JS; Husni, ME; Karlson, EW; Phillips, K | 1 |
Harris, E; Jackson, N; Jones, L; Mahendra, P; Paneesha, S | 1 |
Ben Maïz, H; Ben Taarit, C; Turki, S | 1 |
Wilms, K | 1 |
Burchenal, JH | 1 |
Remington, JS; Wing, EJ | 1 |
Walters, TR | 1 |
Pochedly, C | 1 |
Coltman, CA; Delaney, FC; Panettiere, FJ | 1 |
Holm, O | 1 |
Arranz, R; Cámara, R; Fernández-Rañada, JM; Figuera, A; Pérez, G; Steegmann, JL; Tomás, JF; Vazquez, L | 1 |
Brecher, M; Crist, W; Harris, MB; Krance, RA; Land, VJ; Newman, EM; Pullen, J; Ravindranath, Y; Shuster, JJ; Wimmer, R | 1 |
Aschan, J; Båryd, I; Janossy, G; Ljungman, P; Lönnqvist, B; Markling, L; Pihlstedt, P; Ringdén, O; Sundberg, B; Tollemar, J | 1 |
Luthra, HS | 1 |
Berry, D; Crist, W; Doering, E; Fernbach, D; Pullen, J; Shuster, J; van Eys, J; Wharam, M | 1 |
Sullivan, KM | 1 |
Sanders, JE | 1 |
Davis, RE | 1 |
Deeg, HJ; Storb, R | 1 |
Chessells, JM; Hardisty, RM; Leiper, AD; Richards, S; Tiedemann, K | 1 |
Bloch, D; Fries, J; Sherrer, Y; Strober, S | 1 |
Beschorner, WE; Clark, AW; Patchell, RA; Santos, GW; White, CL | 1 |
Nakamoto, S; Popowniak, KL | 1 |
Vogt, D | 1 |
Buckner, CD; Fefer, A; Glucksberg, H; Lerner, KG; Neiman, P; Storb, R; Thomas, ED | 1 |
Amiel, JL; Cattan, A; Hayat, M; Jasmin, C; Mathé, G; Schlumberger, JR; Schneider, M; Schwarzenberg, L | 1 |
Chavez, CM; Conn, JH; Fain, WR | 1 |
Bilder, J; Hornová, J | 1 |
Baum, ES; Chapman, KE; Haerr, M; Hays, T; Holton, CP; Hutter, JJ; Mayer, CM; Phillips, LK | 1 |
Aur, RJ; Hustu, HO; Simone, JV; Verzosa, MS | 1 |
Hughes, WT; Smith, DR | 1 |
Simone, J | 1 |
Burchenal, JH; Clarkson, BD; Haghbin, M; Miké, V; Murphy, ML; Tan, CC | 1 |
Cebrian Bonesana, A; De Macchi, GH; Eppinger-Helft, M; Hidalgo, G; Pavlovsky, A; Pavlovsky, S; Peñalver, JA; Sackmann Muriel, F | 1 |
Schnitzer, A | 1 |
Baden, HP; Goldsmith, LA | 1 |
Braun, HJ | 1 |
Bodey, GP; Freireich, EJ; Rodriguez, V | 1 |
Forbes, IJ | 1 |
Blaszczyk, M; Chorzelski, T; Jablonska, S | 1 |
Blumenstock, DA; Grosjean, OB; Mulder, MA; Otte, HP | 1 |
Grob, PJ | 1 |
Hughes, WT | 1 |
Fernbach, DJ; Gooch, WM | 1 |
Zubrod, CG | 1 |
Farber, EM; Watson, W | 1 |
28 review(s) available for methotrexate and Infection
Article | Year |
---|---|
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options.
Topics: Anti-Infective Agents; Antimalarials; Biological Therapy; Comorbidity; Dermatologic Agents; Diabetes Complications; Diagnosis, Differential; Glucocorticoids; Granuloma Annulare; Humans; Iatrogenic Disease; Infections; Methotrexate; Neoplasms; Pentoxifylline; Phosphodiesterase 4 Inhibitors; Phototherapy; Piperidines; Pyrimidines; Thalidomide | 2022 |
[Comorbidities-Their role in the treat to target concept for rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Comorbidity; Humans; Infection Control; Infections; Methotrexate; Remission Induction | 2019 |
Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Infections; Longitudinal Studies; Male; Methotrexate; Middle Aged; Piperidines; Prevalence; Proportional Hazards Models; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Young Adult | 2014 |
[Risk of serious infection in patients with rheumatoid arthritis].
Topics: Age Factors; Arthritis, Rheumatoid; Biological Products; Comorbidity; Diabetes Mellitus; Female; Glucocorticoids; Humans; Incidence; Infections; Lung Diseases; Male; Methotrexate; Risk; Risk Factors; Severity of Illness Index; Sex Factors; Time Factors; Tumor Necrosis Factor-alpha | 2015 |
Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Products; Biological Therapy; Humans; Infections; Methotrexate; Odds Ratio; Phototherapy; Proportional Hazards Models; Psoriasis; Randomized Controlled Trials as Topic; Retinoids; Risk Factors; Time Factors; Ustekinumab | 2016 |
DMARDS and infections in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Infections; Isoxazoles; Leflunomide; Methotrexate; Risk Factors | 2008 |
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Humans; Infections; Long-Term Care; Methotrexate; Neoplasms; Pneumonia; Risk Factors | 2009 |
[Tocilizumab in rheumatoid arthritis].
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Disease Susceptibility; Drug Therapy, Combination; Humans; Hypercholesterolemia; Infections; Methotrexate; Multicenter Studies as Topic; Receptors, Interleukin-6 | 2011 |
B-cell therapies in established rheumatoid arthritis.
Topics: Agammaglobulinemia; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; B-Lymphocytes; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infections; Male; Methotrexate; Randomized Controlled Trials as Topic; Rituximab; Treatment Failure | 2011 |
[Etanercept].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Etanercept; Humans; Immunoglobulin G; Infections; Methotrexate; Receptors, Tumor Necrosis Factor | 2002 |
Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Family; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Histocompatibility Testing; HLA Antigens; Host vs Graft Reaction; Humans; Infections; Male; Methotrexate; Middle Aged; Parents; Risk; Siblings; Survival Analysis; Survival Rate; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |
Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Susceptibility; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infections; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Interleukin-1; Sialoglycoproteins; Treatment Outcome | 2004 |
Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
Topics: Adolescent; Age Factors; Autoimmune Diseases; Child; Child, Preschool; Cyclosporine; Disease Susceptibility; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infections; Lymphoma; Male; Methotrexate; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; Skin Diseases | 2005 |
Spinal cord disorders in patients with cancer.
Topics: Anemia, Pernicious; Central Nervous System Diseases; Encephalomyelitis; Humans; Infections; Methotrexate; Motor Neurons; Neoplasm Metastasis; Neoplasms; Nerve Degeneration; Neuromuscular Diseases; Paraneoplastic Syndromes; Radiation Injuries; Spinal Cord; Spinal Cord Diseases; Spinal Cord Injuries | 1984 |
Methotrexate in juvenile rheumatoid arthritis. Do the benefits outweigh the risks?
Topics: Arthritis, Juvenile; Arthritis, Rheumatoid; Humans; Infections; Kidney; Liver; Methotrexate; Reproduction; Risk | 1993 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
[Adult Still's disease: study of a series of 11 cases].
Topics: Adult; Anemia; Diagnosis, Differential; Exanthema; Female; Ferritins; Fever; Humans; Incidence; Infections; Liver Function Tests; Male; Methotrexate; Neoplasms; Pain; Prednisone; Prevalence; Retrospective Studies; Still's Disease, Adult-Onset | 2002 |
Cell-mediated immunity and its role in resistance to infection.
Topics: Adrenal Cortex Hormones; Animals; Child; Cyclophosphamide; Helminthiasis; Hodgkin Disease; Humans; Hypersensitivity, Delayed; Immune System Diseases; Immunity; Immunity, Cellular; Infections; Listeriosis; Lymphocyte Activation; Measles; Methotrexate; Mice; Mycoses; Protozoan Infections; T-Lymphocytes; Virus Diseases | 1977 |
The definitive treatment of children with acute leukemia.
Topics: Asparaginase; Central Nervous System Diseases; Child; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Humans; Immunotherapy; Infections; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Neoplasms, Multiple Primary; Prednisone; Psychology; Remission, Spontaneous; Vincristine | 1976 |
Acute and chronic graft-versus-host disease in man.
Topics: Acute Disease; Age Factors; Bone Marrow Transplantation; Chronic Disease; Cyclosporins; Drug Therapy, Combination; Graft vs Host Disease; HLA Antigens; Humans; Immune Tolerance; Immunosuppression Therapy; Infections; Methotrexate; Prednisolone; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory | 1986 |
Clinical chemistry of folic acid.
Topics: Absorption; Aged; Alcoholism; Anemia, Sickle Cell; Anticonvulsants; Arthritis, Rheumatoid; Biological Assay; Biological Transport; Bone Marrow; Carrier Proteins; Chemical Phenomena; Chemistry; Contraceptives, Oral; Female; Folate Receptors, GPI-Anchored; Folic Acid; Folic Acid Antagonists; Folic Acid Deficiency; Food Analysis; Formiminoglutamic Acid; Glutamate Formimidoyltransferase; Humans; Hydroxymethyl and Formyl Transferases; Infant; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infections; Kidney Failure, Chronic; Malabsorption Syndromes; Malaria; Methotrexate; Neoplasms; Nervous System Diseases; Nutritional Requirements; Parenteral Nutrition, Total; Pregnancy; Pyrimethamine; Receptors, Cell Surface; Terminology as Topic; Thalassemia; Transferases; Trimethoprim | 1986 |
Immunosuppressive therapy in renal transplantation.
Topics: Adolescent; Adult; Animals; Anticoagulants; Antigens; Antilymphocyte Serum; Asparaginase; Azathioprine; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Dogs; Drainage; Evaluation Studies as Topic; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppression Therapy; Infections; Kidney Transplantation; Lectins; Male; Methods; Methotrexate; Middle Aged; Phenothiazines; Procarbazine; Rabbits; Radiation Effects; Thoracic Duct; Transplantation, Homologous | 1971 |
Cytotoxic drugs in treatment of nonmalignant diseases.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Granulomatosis with Polyangiitis; Hepatitis; Humans; Immune Complex Diseases; Immunosuppressive Agents; Infections; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Nephrotic Syndrome; Ophthalmia, Sympathetic; Psoriasis; Thioguanine; Uveitis | 1972 |
Management and treatment of ichthyosis.
Topics: Antimetabolites; Baths; Climate; Counseling; Female; Fetal Diseases; Humans; Humidity; Ichthyosis; Infections; Methotrexate; Occlusive Dressings; Ointments; Pregnancy; Propylene Glycols; Solutions; Vitamin A | 1972 |
[Clinical picture, diagnostics and therapy of amyloidoses].
Topics: Adrenal Gland Diseases; Amyloidosis; Biopsy; Chloroquine; Chronic Disease; Gastrointestinal Diseases; Humans; Infections; Kidney Diseases; Liver Diseases; Methotrexate; Neoplasms; Pancreatic Diseases; Prognosis; Splenic Diseases | 1972 |
Combination chemotherapy for lymphomas and leukemias.
Topics: Adult; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Hodgkin Disease; Humans; Immunotherapy; Infections; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Mercaptopurine; Methotrexate; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Vincristine | 1973 |
Immunosuppressants in the treatment of pemphigus.
Topics: Adult; Aged; Azathioprine; Drug Resistance, Microbial; Female; Humans; Infections; Male; Methotrexate; Middle Aged; Mucous Membrane; Pemphigus; Prednisone; Skin Diseases; Triamcinolone | 1970 |
[Current status of immunosuppressive therapy in non-neoplastic disorders].
Topics: Arthritis; Autoimmune Diseases; Azathioprine; Bone Marrow; Bone Marrow Diseases; Chemical Phenomena; Chemistry; Cyclophosphamide; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Kidney Diseases; Methotrexate; Prognosis; Skin Diseases | 1970 |
55 trial(s) available for methotrexate and Infection
Article | Year |
---|---|
Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial.
Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Bronchitis; Cellulitis; Chemical and Drug Induced Liver Injury; Chickenpox; Child; Child, Preschool; Female; Glucocorticoids; Humans; Infections; Male; Methotrexate; Patient Reported Outcome Measures; Pneumonia; Treatment Outcome | 2021 |
Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
Topics: Abatacept; Antirheumatic Agents; Arthritis, Juvenile; Child; Humans; Infections; Methotrexate; Treatment Outcome | 2021 |
Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Creatine Kinase; Double-Blind Method; Drug Therapy, Combination; Female; Herpes Zoster; Heterocyclic Compounds, 3-Ring; Humans; Infections; Janus Kinase Inhibitors; Male; Methotrexate; Middle Aged; Severity of Illness Index; Venous Thromboembolism | 2019 |
Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan.
Topics: Adamantane; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Substitution; Female; Herpes Zoster; Humans; Immunosuppressive Agents; Infections; Janus Kinase Inhibitors; Japan; Male; Methotrexate; Middle Aged; Niacinamide; Severity of Illness Index; Treatment Outcome | 2019 |
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Immunocompetence; Infections; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Palliative Care; Prednisolone; Recurrence; Remission Induction; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Vindesine | 2014 |
Sustained remission with etanercept tapering in early rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Infections; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Remission Induction; Withholding Treatment | 2014 |
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study.
Topics: Adult; Aged; Allografts; Anti-Inflammatory Agents; Cannabidiol; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Prospective Studies; Young Adult | 2015 |
Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Humans; Infant; Infections; Injections, Intraventricular; Male; Medulloblastoma; Methotrexate; Multivariate Analysis; Neoplasm Metastasis; Outcome Assessment, Health Care; Proportional Hazards Models; Prospective Studies; Young Adult | 2015 |
Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Certolizumab Pegol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Time Factors; Treatment Outcome | 2015 |
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Topics: Acute Kidney Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Comparative Effectiveness Research; Cytarabine; Death, Sudden; Denmark; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Diseases; Germany; Heart Injuries; Hematopoietic Stem Cell Transplantation; Humans; Hyperglycemia; Induction Chemotherapy; Infections; Intraocular Lymphoma; Italy; Kaplan-Meier Estimate; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mucositis; Neurotoxicity Syndromes; Neutropenia; Optic Nerve Neoplasms; Poisoning; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Stroke; Switzerland; Thiotepa; Thrombocytopenia; Thrombosis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; United Kingdom | 2016 |
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Certolizumab Pegol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infections; Male; Methotrexate; Middle Aged; Prognosis; Radiography; Remission Induction | 2017 |
Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Female; Headache; Humans; Infections; Injections; Male; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Retreatment; Severity of Illness Index | 2017 |
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1).
Topics: Administration, Oral; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Hemoglobins; Humans; Infections; Janus Kinase 1; Male; Methotrexate; Middle Aged; Protein Kinase Inhibitors; Pyridines; Severity of Illness Index; Surveys and Questionnaires; Triazoles | 2017 |
Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2).
Topics: Administration, Oral; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hemoglobins; Humans; Infections; Janus Kinase 1; Male; Methotrexate; Middle Aged; Protein Kinase Inhibitors; Pyridines; Retreatment; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Triazoles | 2017 |
Rheumatoid arthritis triple therapy compared with etanercept: difference in infectious and gastrointestinal adverse events.
Topics: Abscess; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Female; Gastritis; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Ileus; Incidence; Infections; Intestinal Obstruction; Linear Models; Male; Methotrexate; Middle Aged; Pancreatitis; Pneumonia; Respiratory Tract Infections; Sulfasalazine; Urinary Tract Infections | 2017 |
A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.
Topics: Adult; Alefacept; CD4 Lymphocyte Count; Cyclosporine; Dermatologic Agents; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Infections; Lymphopenia; Male; Methotrexate; Middle Aged; Neoplasms; Psoriasis; Recombinant Fusion Proteins; Retinoids; Retreatment; Treatment Outcome; Ultraviolet Therapy | 2008 |
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response.
Topics: Adolescent; Child; Child, Preschool; Dexamethasone; Female; Glucocorticoids; Glutathione Transferase; Humans; Infant; Infections; Male; Methotrexate; Pharmacogenetics; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone | 2009 |
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infections; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Recombinant Proteins; Survival Rate; Vincristine; Young Adult | 2010 |
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies.
Topics: Adult; Aged; Animals; Anti-Infective Agents; Antilymphocyte Serum; Busulfan; Disease Susceptibility; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Infection Control; Infections; Male; Medical Audit; Methotrexate; Middle Aged; Myeloablative Agonists; Patient Isolation; Postoperative Complications; Rabbits; T-Lymphocytes; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult | 2009 |
The AMBITION trial: tocilizumab monotherapy for rheumatoid arthritis.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; C-Reactive Protein; Disease Progression; Double-Blind Method; Female; Humans; Infections; Male; Methotrexate; Middle Aged; Neutropenia; Receptors, Interleukin-6; Treatment Outcome | 2010 |
[Clinical tolerance of high-dose methotrexate used in consolidation therapy in children with acute lymphoblastic leukemia].
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Incidence; Infant; Infections; Male; Methotrexate; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vomiting | 2010 |
Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Follow-Up Studies; Genetic Markers; Hematologic Diseases; Humans; Infections; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Methotrexate; Middle Aged; Prospective Studies; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2012 |
Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Infections; Infusions, Intravenous; Joints; Male; Methotrexate; Middle Aged; Severity of Illness Index; Treatment Outcome | 2012 |
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Arthritis, Juvenile; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Infections; Male; Methotrexate; Neutropenia; Receptors, Interleukin-6; Transaminases | 2012 |
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Juvenile; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Infections; Interleukin-1beta; Kaplan-Meier Estimate; Macrophage Activation Syndrome; Male; Methotrexate; Neutropenia; Thrombocytopenia | 2012 |
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow
Topics: Adolescent; Adult; Age Factors; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Child; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Hemorrhage; Humans; Idarubicin; Infections; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Middle Aged; Remission Induction; Treatment Outcome; Vomiting | 2002 |
High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Bone Marrow Diseases; Burkitt Lymphoma; Comorbidity; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Carriers; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Infections; Leukemia, T-Cell; Life Tables; Liposomes; Male; Methotrexate; Middle Aged; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction; Safety; Survival Analysis; Topotecan; Treatment Outcome | 2003 |
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Deoxycytidine; Docetaxel; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Infections; Male; Methotrexate; Middle Aged; Neutropenia; Prognosis; Survival Analysis; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2005 |
Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Etanercept; Female; Humans; Immunoglobulin G; Infections; Joints; Longitudinal Studies; Male; Methotrexate; Middle Aged; Neoplasms; Receptors, Tumor Necrosis Factor; Risk; Risk Assessment; Time Factors; Treatment Outcome | 2006 |
The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trial.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Infections; Infliximab; Male; Methotrexate; Middle Aged; Risk Assessment; Severity of Illness Index | 2006 |
Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.
Topics: Abatacept; Adult; Aged; Antibody Formation; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Double-Blind Method; Drug Resistance; Female; Humans; Immunoconjugates; Infections; Male; Methotrexate; Middle Aged; Quality of Life; Radiography; Treatment Outcome | 2006 |
Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Topics: Acute Disease; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Down Syndrome; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Infant; Infections; Japan; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Methotrexate; Mitoxantrone; Remission Induction; Survival Analysis; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Tretinoin; Vincristine | 2007 |
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Hematologic Diseases; Humans; Hydrocortisone; Infant; Infections; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Treatment Outcome; Vincristine | 2008 |
Use of methotrexate and 5-FU for recurrent head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Diarrhea; Drug Therapy, Combination; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infections; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia | 1982 |
Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Histocompatibility; Humans; Incidence; Infections; Male; Methotrexate; Methylprednisolone; Survival Rate | 1995 |
CVM versus ACE in the treatment of small cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant, Newborn; Infections; Leukopenia; Lung Neoplasms; Male; Methotrexate; Middle Aged; Thrombocytopenia; Treatment Outcome; Vinblastine | 1993 |
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infections; Karyotyping; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Regression Analysis; Survival Rate; Treatment Outcome; Whole-Body Irradiation | 1996 |
Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Infections; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neutropenia; Recombinant Proteins; Stomatitis; Thrombocytopenia; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer. Results of a prospective, controlled, randomized clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bandages; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drainage; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infections; Length of Stay; Lymph; Methotrexate; Middle Aged; Postoperative Complications; Prospective Studies; Treatment Outcome; Wound Healing | 1997 |
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Disease-Free Survival; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Infections; Kidney Diseases; Life Tables; Liver Diseases; Male; Methotrexate; Middle Aged; Pilot Projects; Safety; Survival Analysis; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 1997 |
Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Deafness; Disease Progression; Disease-Free Survival; Etoposide; Follow-Up Studies; Glioma; Hearing Loss; Hematologic Diseases; Humans; Ifosfamide; Infections; Life Tables; Lomustine; Medulloblastoma; Methotrexate; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Vincristine | 1998 |
Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infections; Male; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Proportional Hazards Models; Remission Induction; Risk; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine | 2000 |
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Bone and Bones; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Hospitalization; Humans; Infections; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Nuclear Family; Prospective Studies; Recurrence; Survival Rate | 2000 |
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Infections; Leukemia; Lymphocyte Depletion; Lymphoma; Male; Methotrexate; Middle Aged; Survival Analysis; Time Factors; Tissue Donors; Transplantation, Homologous | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Infections; Lymphoma, Non-Hodgkin; Male; Methotrexate; Morbidity; Neutropenia; Prednisone; Stomatitis; Vincristine | 2002 |
Experience with etanercept in an academic medical center: are infection rates increased?
Topics: Academic Medical Centers; Antirheumatic Agents; Etanercept; Female; Humans; Immunoglobulin G; Immunologic Factors; Infections; Male; Massachusetts; Methotrexate; Middle Aged; Prednisone; Receptors, Tumor Necrosis Factor; Rheumatic Diseases | 2002 |
Unexpectedly high toxicity of MACOP-B in young patients with low grade lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Granulocytes; Humans; Infections; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Vincristine | 1991 |
A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Female; Fever; Humans; Infant; Infections; Length of Stay; Leukocyte Count; Male; Methotrexate; Neutropenia; Pilot Projects; Platelet Count; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Survival Rate | 1991 |
Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients.
Topics: Adult; Blood Transfusion; Bone Marrow Transplantation; Cyclosporins; Graft vs Host Disease; Humans; Infections; Leukemia; Lymphocyte Depletion; Methotrexate; T-Lymphocytes | 1991 |
A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Humans; Hydrocortisone; Infant; Infant, Newborn; Infections; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Random Allocation; Remission Induction; Vincristine | 1989 |
Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Infections; Injections, Intramuscular; Leukemia, Lymphoid; Male; Methotrexate; Prognosis; Prospective Studies; Random Allocation | 1987 |
Acute lymphocytic leukemia in children: maintenance therapy with methotrexat administered intermittently. Acute Leukemia Group B.
Topics: Adolescent; Adult; Blood Platelets; Bone Marrow Cells; Bone Marrow Examination; Child; Child, Preschool; Dyspnea; Female; Gastrointestinal Diseases; Hemoglobins; Herpesviridae Infections; Humans; Infant; Infant, Newborn; Infections; Injections, Intramuscular; Leukemia, Lymphoid; Leukocyte Count; Leukopenia; Male; Methotrexate; Mouth Diseases; Neurologic Manifestations; Osteoporosis; Pneumonia; Pneumonia, Pneumocystis; Prednisolone; Respiratory Tract Diseases; Thrombocytopenia; Vincristine | 1969 |
A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia.
Topics: Adolescent; Adult; Blood Transfusion, Autologous; Brain Neoplasms; Child; Child, Preschool; Cobalt Isotopes; Cyclophosphamide; Female; Humans; Infant; Infections; Injections, Intravenous; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Radiation Dosage; Radiation Effects; Remission, Spontaneous; Spinal Cord Neoplasms; Time Factors | 1972 |
Acute lymphocytic leukemia in childhood.
Topics: Asparaginase; Black People; Bone Marrow Examination; Central Nervous System Diseases; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunosuppression Therapy; Infections; Injections, Spinal; Leukemia, Lymphoid; Leukopenia; Male; Methotrexate; Prednisone; Remission, Spontaneous; Vincristine | 1974 |
74 other study(ies) available for methotrexate and Infection
Article | Year |
---|---|
Infectious risk of add-on leflunomide or tacrolimus versus TNF inhibitors among patients with rheumatoid arthritis receiving background methotrexate: A population-based cohort study.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Herpes Zoster; Humans; Infections; Leflunomide; Methotrexate; Tacrolimus; Tumor Necrosis Factor Inhibitors | 2022 |
[Lower risk of severe infections in psoriasis with certain biologics versus methotrexate].
Topics: Biological Products; Humans; Infections; Methotrexate; Psoriasis; Ustekinumab | 2019 |
Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy.
Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Glucocorticoids; Humans; Infections; Methotrexate; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience.
Topics: Adult; Allografts; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Immunologic; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Recurrence; Retrospective Studies; T-Lymphocytes; Unrelated Donors | 2021 |
Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019.
Topics: Adult; Cross-Sectional Studies; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Infections; Insurance, Health; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Risk Factors; United States; Young Adult | 2021 |
Real-world clinical experience of biological disease modifying anti-rheumatic drugs in Malaysia rheumatoid arthritis patients.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Drug Therapy, Combination; Female; Humans; Hypersensitivity; Infections; Malaysia; Male; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies.
Topics: Antibodies; Antirheumatic Agents; Drug Therapy, Combination; Female; Humans; Immunoglobulins; Infections; Male; Medication Adherence; Methotrexate; Middle Aged; Rheumatic Fever; Rituximab; Treatment Outcome | 2017 |
Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Female; Humans; Infections; Male; Methotrexate; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Treatment Outcome | 2018 |
Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
Topics: Adult; Biological Factors; Dermatologic Agents; Female; Follow-Up Studies; Humans; Incidence; Infections; Infliximab; Ireland; Male; Methotrexate; Middle Aged; Prospective Studies; Psoriasis; Registries; Severity of Illness Index; United Kingdom | 2019 |
Risk of Serious Infection Among Initiators of Tumor Necrosis Factor Inhibitors Plus Methotrexate Versus Triple Therapy for Rheumatoid Arthritis: A Cohort Study.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Drug Therapy, Combination; Female; Humans; Infections; Male; Methotrexate; Middle Aged; Tumor Necrosis Factor Inhibitors | 2020 |
Use of biologics in a patient with rheumatoid arthritis refractory to methotrexate.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Humans; Infections; Methotrexate; Treatment Failure; Tuberculin Test | 2013 |
Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials, Phase III as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infections; Male; Meta-Analysis as Topic; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome | 2014 |
Anti-TNF-α and risk of infections: the experience in one center.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Certolizumab Pegol; Chronic Disease; Comorbidity; Etanercept; Female; Herpes Zoster; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Infections; Infliximab; Male; Medical Records; Methotrexate; Middle Aged; Odds Ratio; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Risk Factors; Tumor Necrosis Factor-alpha; Urinary Tract Infections | 2014 |
Expert Recommendations on Treating Psoriasis in Special Circumstances (Part II).
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Biological Therapy; Child; Clinical Trials as Topic; Combined Modality Therapy; Delphi Technique; Disease Management; Disease Susceptibility; Etanercept; Humans; Immunosuppressive Agents; Infections; Methotrexate; Psoriasis; Quality of Life; Surveys and Questionnaires; Ultraviolet Therapy | 2016 |
Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis.
Topics: Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Factors; Case-Control Studies; Chi-Square Distribution; Female; Glucocorticoids; Hospitalization; Humans; Incidence; Infections; Kaplan-Meier Estimate; Logistic Models; Male; Methotrexate; Prednisolone; Retrospective Studies; Risk; Statistics, Nonparametric | 2017 |
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Demyelinating Diseases; Drug Substitution; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Infliximab; Infusions, Intravenous; Lymphoproliferative Disorders; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Mortality; Narcotics; Prednisone; Prospective Studies; Registries; Risk Factors; Sulfasalazine; Time Factors; Young Adult | 2017 |
Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection.
Topics: Adolescent; Adrenal Cortex Hormones; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Case-Control Studies; CD4-CD8 Ratio; Child; Child, Preschool; Female; Humans; Immunoglobulins; Infections; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vincristine | 2008 |
Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Epidemiologic Methods; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infections; Male; Methotrexate; Middle Aged; Opportunistic Infections; Prednisone; Tumor Necrosis Factor-alpha; United States | 2010 |
[Epidemiology of pemphigus in the Hospital Universitario Virgen Macarena, Seville, Spain, 2005-2006].
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cushing Syndrome; Drug Therapy, Combination; Female; Hospitals, University; Hospitals, Urban; Humans; Hypertension; Immunosuppressive Agents; Infections; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pemphigus; Retrospective Studies; Spain | 2009 |
Methotrexate treatment in rheumatoid arthritis: management in clinical remission, common infection and tuberculosis. Results from a systematic literature review.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Evidence-Based Medicine; Humans; Infections; Methotrexate; Tuberculosis | 2010 |
Leflunomide in combination therapy for rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Australia; Drug Therapy, Combination; Humans; Infections; Isoxazoles; Leflunomide; Methotrexate; New Zealand; Pancytopenia; Pneumonia | 2010 |
Twelve years' experience with etanercept in the treatment of rheumatoid arthritis: how it has changed clinical practice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Synergism; Etanercept; Humans; Immunoglobulin Fc Fragments; Immunoglobulin G; Infections; Lymphoma; Methotrexate; Practice Patterns, Physicians'; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Tumor Necrosis Factor-alpha | 2012 |
[Anti-rheumatic drugs].
Topics: Antirheumatic Agents; Cysteine; Hematologic Diseases; Humans; Hypersensitivity; Infections; Isoxazoles; Kidney Diseases; Leflunomide; Liver Neoplasms; Lung Diseases; Methotrexate | 2012 |
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infections; Life Tables; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Spain; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; United Kingdom; Vidarabine | 2002 |
Baboons undergoing orthotopic concordant cardiac xenotransplantation surviving more than 300 days: effect of immunosuppressive regimen.
Topics: Actuarial Analysis; Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Macaca mulatta; Methotrexate; Papio; Splenectomy; Tacrolimus; Time Factors; Transplantation, Heterologous | 2003 |
LEUKEMIA.
Topics: Antineoplastic Agents; Blood Transfusion; Bone Marrow Transplantation; Child; Chromosome Aberrations; Humans; Infections; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Methotrexate; Mortality; Neoplasms; Oncogenic Viruses; Research | 1964 |
[44-year-old female patient with cutaneous rash, sore throat, fever and arthritis].
Topics: Adrenal Cortex Hormones; Adult; Arthritis; Diagnosis, Differential; Exanthema; Female; Fever of Unknown Origin; Humans; Immunosuppressive Agents; Infections; Methotrexate; Neoplasms; Pharyngitis; Secondary Prevention; Still's Disease, Adult-Onset; Treatment Failure; Treatment Outcome | 2003 |
Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Hyperglycemia; Infections; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Time Factors; Vincristine | 2004 |
Immunosuppressants, infection, and inflammation.
Topics: Arthralgia; Arthritis, Juvenile; Child, Preschool; Fever; Humans; Immunosuppressive Agents; Infections; Inflammation; Male; Methotrexate; Naproxen | 2004 |
Infliximab therapy in established rheumatoid arthritis: an observational study.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Infections; Infliximab; Male; Methotrexate; Middle Aged; Patient Compliance; Proportional Hazards Models | 2005 |
Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol.
Topics: Acute Disease; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cytarabine; Daunorubicin; Developing Countries; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Infant; Infections; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Prednisone; Remission Induction; Retrospective Studies; Singapore; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine | 2007 |
Summaries for patients. Abatacept for people with active rheumatoid arthritis.
Topics: Abatacept; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Resistance; Female; Humans; Immunoconjugates; Infections; Male; Methotrexate; Middle Aged; Quality of Life; Radiography; Treatment Outcome | 2006 |
IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
Topics: Adult; Aged; Antibodies, Anticardiolipin; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infections; Infliximab; Male; Methotrexate; Middle Aged; Placebos | 2006 |
Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
Topics: Adolescent; Alemtuzumab; Anemia, Aplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppressive Agents; Infant; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Retrospective Studies; Siblings; Survival Analysis; T-Lymphocyte Subsets; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2006 |
Comment on Pavy et al.'s original article "Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion".
Topics: Arthritis, Rheumatoid; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Infections; Methotrexate; Perioperative Care; Practice Guidelines as Topic | 2007 |
Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Immunotherapy; Infections; Injections, Spinal; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Methotrexate; Methylprednisolone; Recurrence; Retrospective Studies; Treatment Outcome | 2007 |
The management of acute leukemia.
Topics: Adult; Anti-Bacterial Agents; Child; Cyclophosphamide; Hemorrhage; Humans; Infections; Leukemia, Lymphoid; Mercaptopurine; Methotrexate; Prednisone; Prognosis; Uric Acid; Vincristine | 1967 |
Management of drug toxicities and infections.
Topics: Antineoplastic Agents; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Humans; Infections; Methotrexate; Neoplasms | 1980 |
Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Rheumatoid; Female; Humans; Infections; Male; Methotrexate; Middle Aged; Prospective Studies; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Skin Diseases, Infectious; Urinary Tract Infections | 1994 |
Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topics: Actuarial Analysis; Acute Disease; Adult; Anti-Infective Agents; Bone Marrow Transplantation; Busulfan; Cause of Death; Critical Care; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Histocompatibility; HLA-DR Antigens; Humans; Immunosuppressive Agents; Infections; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Risk; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1996 |
Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Infections; Interleukin-12; Male; Methotrexate; Middle Aged; Transplantation, Autologous; Transplantation, Homologous | 1996 |
Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis).
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Infections; Life Tables; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Survival Rate; Transplantation, Homologous | 1998 |
Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.
Topics: Adolescent; Adult; Antigens, CD19; Antigens, CD34; B-Lymphocyte Subsets; CD4 Antigens; CD8 Antigens; Cell Separation; Chimera; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Infections; Killer Cells, Natural; Kinetics; Leukapheresis; Leukocyte Common Antigens; Lymphocyte Count; Lymphocyte Depletion; Lymphocyte Subsets; Male; Methotrexate; Methylprednisolone; Middle Aged; Prospective Studies; T-Lymphocyte Subsets; Time Factors; Transplantation Conditioning; Whole-Body Irradiation | 1999 |
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Child; Child, Preschool; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infections; Liver Failure; Magnesium Deficiency; Male; Methotrexate; Survival Rate; Tacrolimus; Time Factors; Transplantation, Homologous; Vascular Diseases | 2000 |
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Purging; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Cystitis; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Infections; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Pilot Projects; Salvage Therapy; Survival Analysis; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2000 |
Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cause of Death; Cyclosporine; Female; Gastrointestinal Hemorrhage; Graft vs Host Disease; Hematologic Neoplasms; Humans; Hypertension; Infections; Male; Methotrexate; Middle Aged; Musculoskeletal Diseases; Prednisone; Retrospective Studies; Survival Analysis; Therapeutic Equivalency; Transplantation, Homologous | 2001 |
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antilymphocyte Serum; Bone Marrow; Busulfan; Cell Count; Chromosomes, Human, Pair 7; Cyclophosphamide; Disease-Free Survival; Feasibility Studies; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Histocompatibility; Humans; Infections; Karyotyping; Methotrexate; Middle Aged; Monosomy; Myelodysplastic Syndromes; Recurrence; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |
Burkitt's lymphoma: single-centre experience with modified BFM protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infections; Lymphoma, AIDS-Related; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission Induction; Treatment Outcome; Vincristine | 2002 |
[Bone marrow transplantation in malignant lymphomas?].
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Dogs; Graft vs Host Reaction; Histocompatibility; Hodgkin Disease; Humans; Immunologic Deficiency Syndromes; Infections; Lymphoma; Methotrexate; Transplantation, Homologous | 1976 |
From wild fowl to stalking horses: alchemy in chemotherapy. Fifth annual David A. Karnofsky Memorial Lecture.
Topics: Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Asparaginase; Brain Neoplasms; Drug Therapy, Combination; History, 20th Century; Hodgkin Disease; Humans; Infections; Leukemia; Lymphoma; Methotrexate; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds; Osteosarcoma; Rhabdomyosarcoma; Sarcoma, Ewing; Wilms Tumor | 1975 |
Neurotoxicity due to CNS therapy for leukemia.
Topics: Adolescent; Brain Diseases; Central Nervous System Diseases; Child; Humans; Infections; Leukemia; Methotrexate; Paralysis; Radiotherapy; Spinal Cord Diseases | 1977 |
Splenectomy, chemotherapy, and survival in Hodgkin disease.
Topics: Dactinomycin; Follow-Up Studies; Hodgkin Disease; Humans; Infections; Methotrexate; Prognosis; Remission, Spontaneous; Splenectomy; Time Factors; Vinblastine | 1977 |
[Immunologic tissue damage and immunosuppression].
Topics: Abnormalities, Drug-Induced; Azathioprine; Cortisone; Cyclophosphamide; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Infertility; Male; Mercaptopurine; Methotrexate; Neoplasms; T-Lymphocytes | 1976 |
Felty's syndrome: a therapeutic dilemma?
Topics: Antigen-Antibody Complex; Felty Syndrome; Humans; Infections; Leukopenia; Methotrexate; Neutropenia; Splenectomy | 1989 |
Bone marrow transplantation as treatment of hematologic disease.
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Combined Modality Therapy; Female; Graft vs Host Disease; Hematologic Diseases; HLA Antigens; Humans; Infections; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphocyte Culture Test, Mixed; Methotrexate; Tissue Donors; Whole-Body Irradiation | 1986 |
Acute and chronic graft-versus-host disease: clinical manifestations, prophylaxis, and treatment.
Topics: Acute Disease; Age Factors; Animals; Chronic Disease; Cyclosporins; Dogs; Glucocorticoids; Graft vs Host Disease; Humans; Infections; Intestinal Diseases; Liver Diseases; Methotrexate; Risk; Skin Diseases | 1986 |
Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Immune Tolerance; Immunosuppressive Agents; Infections; Lymphoid Tissue; Male; Methotrexate; Middle Aged; Radiotherapy | 1987 |
Neurologic complications of bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Brain Diseases, Metabolic; Central Nervous System; Central Nervous System Diseases; Cerebrovascular Disorders; Child; Child, Preschool; Female; Graft vs Host Disease; Humans; Infections; Leukemia; Male; Methotrexate; Middle Aged; Necrosis; Neoplasms; Postoperative Complications; Seizures; Spinal Cord Diseases | 1985 |
[New viewpoints concerning leukemia in children. Treatment of complications].
Topics: Acute Disease; Anemia, Aplastic; Antineoplastic Agents; Child; gamma-Globulins; Humans; Infections; Leukemia; Methotrexate; Pain | 1970 |
Marrow transplantation for aplastic anemia and acute leukemia.
Topics: Anemia, Aplastic; Animals; Bone Marrow Cells; Bone Marrow Transplantation; Child; Cyclophosphamide; Diseases in Twins; Drug Therapy, Combination; Female; Graft vs Host Reaction; Histocompatibility Antigens; Humans; Infections; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphocyte Culture Test, Mixed; Lymphoma; Methods; Methotrexate; Radiotherapy Dosage; Recurrence; Transplantation, Autologous; Transplantation, Homologous | 1974 |
Acute lymphoblastic leukaemia treated with a combination of prednisone, vincristine, and rubidomycin. Value of pathogen-free rooms.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antibiotics, Antineoplastic; Bone Marrow Examination; Child; Child, Preschool; Cyclophosphamide; Drug Synergism; Female; Humans; Infections; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Middle Aged; Patient Isolators; Prednisone; Vincristine | 1967 |
Continuous arterial infusion chemotherapy. Experience with 44 cases.
Topics: Adenocarcinoma; Arteries; Brain Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Catheterization; Chloramphenicol; Facial Neoplasms; Fever; Fluorouracil; Head and Neck Neoplasms; Humans; Infections; Infusions, Parenteral; Leucovorin; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Palliative Care; Penicillins; Stomach Neoplasms; Thoracic Neoplasms | 1967 |
[Proresid-methotrexate combination in chemotherapy of orofacial carcinoma].
Topics: Agranulocytosis; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Humans; Infections; Injections, Intra-Arterial; Leukopenia; Lip Neoplasms; Melanoma; Methotrexate; Mouth Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Tongue Neoplasms | 1970 |
Acute lymphoblastic leukemia of childhood: results of combination therapy.
Topics: Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cystitis; Drug Therapy, Combination; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Infant; Infections; Leukemia; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Pneumonia, Viral; Prednisone; Remission, Spontaneous; Skin Diseases; Vincristine; Viral Vaccines; Virus Diseases | 1974 |
Infection during induction of remission in acute lymphocytic leukemia.
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Infant; Infections; Leukemia, Lymphoid; Leukocyte Count; Male; Methotrexate; Mycoses; Neutrophils; Prednisone; Remission, Spontaneous; Vincristine; Virus Diseases | 1973 |
Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol).
Topics: Administration, Oral; Adolescent; Age Factors; Antineoplastic Agents; Asparaginase; Carmustine; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Hydroxyurea; Infant; Infections; Injections, Intravenous; Leukemia, Lymphoid; Male; Meningitis; Methotrexate; Prednisone; Remission, Spontaneous; Thioguanine; Vincristine | 1974 |
Evaluation of induction of remission, intensification, and central nervous system prophylactic treatment in acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infections; Injections, Spinal; Leukemia, Lymphoid; Leukopenia; Male; Methotrexate; Middle Aged; Radiotherapy Dosage; Remission, Spontaneous | 1974 |
On methotrexate treatment of psoriasis. Model of a cytostatics treatment.
Topics: Age Factors; Alopecia; Atrophy; Carcinoma, Basal Cell; Diarrhea; Gastritis; Gastrointestinal Hemorrhage; Gingival Diseases; Gingivitis, Necrotizing Ulcerative; Humans; Immunologic Deficiency Syndromes; Immunosuppression Therapy; Infections; Inflammation; Methotrexate; Nausea; Psoriasis; Skin Neoplasms; Stomatitis, Aphthous | 1972 |
The clinical use of immunosuppressive drugs.
Topics: Adrenal Cortex Hormones; Aged; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Infections; Male; Methotrexate; Pregnancy; Psoriasis | 1973 |
Transplantation of the lung.
Topics: Animals; Antilymphocyte Serum; Cytotoxicity Tests, Immunologic; Dogs; Extracorporeal Circulation; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infections; Lung; Lung Diseases; Lung Transplantation; Methotrexate; Postoperative Complications; Regional Blood Flow; Tissue Donors; Tissue Preservation; Transplantation Immunology; Transplantation, Homologous | 1969 |
Fatal infections in childhood leukemia.
Topics: Adolescent; Agranulocytosis; Candida; Child; Child, Preschool; Enterocolitis, Pseudomembranous; Escherichia coli; Female; Fever; Humans; Infant; Infections; Leukemia; Male; Mercaptopurine; Methotrexate; Mycoses; Pneumonia; Prednisone; Pseudomonas aeruginosa; Remission, Spontaneous; Sepsis; Staphylococcus; Time Factors; Vincristine | 1971 |
Immunoglobulins during the course of acute leukemia in children. Effects of various clinical factors.
Topics: Acute Disease; Adolescent; Agammaglobulinemia; Antibody Formation; Antineoplastic Agents; Blood Transfusion; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulins; Immunosuppressive Agents; Infant; Infections; Leukemia; Male; Mercaptopurine; Methotrexate; Prednisone; Serum Albumin | 1971 |
The treatment of acute lymphocytic leukemia.
Topics: Animals; Antineoplastic Agents; Asparaginase; Blood Platelets; Bone Marrow Cells; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Models, Animal; Drug Synergism; Hemorrhage; Humans; Infections; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Mice; Prednisone; Prognosis; Thrombocytopenia; Vincristine | 1970 |
Psoriasis in childhood.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Dermatologic Agents; Female; Humans; Infant; Infections; Male; Methotrexate; Middle Aged; Psoriasis; Psychophysiologic Disorders; Racial Groups; Recurrence; Sex Factors; Skin; Skin Diseases, Infectious; Sunlight | 1971 |